Search

everythinglearnresearchcommunity

for

Search:↓

Severe anti-TNF-α induced scalp eruptions often need stopping the drug and using systemic therapy to avoid scarring.

Carbamazepine caused hair loss and skin eruptions in a woman, which improved after stopping the medication.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Some patients on anti-TNF drugs experience a type of hair loss called TAIAPA.

Stopping infliximab and using strong topical steroids can regrow hair lost due to psoriasiform alopecia.

Some children with methylmalonic and propionic acidaemias have skin problems related to their condition and diet.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Stopping adalimumab and starting methotrexate with topical treatments improved the woman's scalp psoriasis and hair regrew.

Scalp psoriasis can cause different types of hair loss, with some patients developing permanent hair loss, and treatment may be stopped due to skin reactions.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

2011 dermatology discussions highlighted stem cell hair treatments, new lichen planopilaris therapies, skin side effects from cancer drugs, emerging allergens, and the link between food allergies and skin issues.

β-blockers can cause skin problems like psoriasis and vitiligo, and doctors should tell patients about these risks.

Beta-blockers can cause rare skin side-effects, which usually improve after stopping the medication.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Some psychoactive drugs can cause skin reactions, with carbamazepine having a higher risk, and stopping the drug and seeing a dermatologist is important.

Anti-TNF therapy can cause hair loss and skin issues.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

Imatinib can cause hair loss due to lichen planopilaris.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Mood stabilizers like lithium and anticonvulsants have side effects that can lead to patients stopping their medication, and managing these effects is important for treatment adherence.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Psoriasis can cause temporary or permanent hair loss.

Stopping the medication infliximab and starting new treatments helped a woman's hair grow back and improved her scalp condition.

The conclusion is that accurate diagnosis of different types of hair loss requires careful examination of tissue samples and understanding of clinical symptoms.

In Singapore, most skin reactions to drugs were in females and Chinese, often caused by painkillers, antibiotics, and some other drugs, with serious cases linked to genetics.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Stopping the use of fluocinolone oil containing balsam fragrance improved hair regrowth in children allergic to it.